Diabetes and dyslipidemia: A new model for transplant coronary artery disease

Circulation

Volumn 97, Issue 21, 1998, Pages 2160-2168

  Hoang, Khanh ^a   Ida Chen, Y D ^a   Reaven, Gerald ^a   Zhang, Lunan ^a   Ross, Heather ^c   Billingham, Margaret ^b   Valantine, Hannah ^a,b  

^a Division of Cardiovascular Research   (Canada)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Animal model; Atherosclerosis; Diabetes mellitus; Lipoproteins; Transplantation

Indexed keywords

LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOINCOMPATIBILITY; HISTOPATHOLOGY; LIPOPROTEIN METABOLISM; MALE; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

EID: 0345563241     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.21.2160     Document Type: Article

References (24)

1. Gao SZ, Schroeder JS, Alderman EL, Hunt SA, Valantine HA, Wiederhold V, Stinson EB. Prevalence of accelerated coronary artery disease in heart transplant survivors: comparison of cyclosporine and azathioprine regimens. Circulation. 1989;80(suppl III):III-100-III-105.
2. Keogh AM, Valantine HA, Hunt SA, Schroeder JS, McIntosh N, Oyer PE, Stinson EB. Impact of proximal or midvessel discrete coronary artery stenoses on survival after heart transplantation. J Heart Lung Transplant. 1992;11:892-901.
3. Johnson DE, Gao SZ, Schroeder JS, DeCampli WM, Billingham ME. The spectrum of coronary artery pathologic findings in human cardiac allografts. J Heart Transplant. 1989;8:349-359.
4. Gao S-Z, Alderman EL, Schroeder JS, Silverman JF, Hunt SA. Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cordiol. 1988;12:334-340.
5. St. Goar FG, Pinto FJ, Alderman EL, Valantine HA, Schroeder JS, Gao S-Z, Stinson EB, Popp RL. Intracoronary ultrasound in cardiac transplant recipients: in vivo evidence of 'angiographically silent' intimal thickening. Circulation. 1992;85:979-987.
6. Gao S-Z, Schroeder JS, Hunt S, Valantine H, Hill I, Stinson E. Influence of graft rejection on incidence of accelerated graft coronary artery disease: a new approach to analysis. J Heart Lung Transplant. 1993;2:29-35.
7. Rickenbacher PR, Kemna MS, Pinto FJ, Hunt SA, Alderman EL, Schroeder JS, Stinson EB, Popp RL, Chen I, Reaven G, Valantine HA. Coronary artery intimal thickening in the transplanted heart: an in vivo intracoronary ultrasound study of correlation with metabolic and immu- nologic factors and donor-recipient demographics. Transplantation. 1996;61:46-53.
8. Kemna MS, Valantine HA, Hunt SA, Schroeder JS, Chen Y-DI, Reaven CM. Metabolic risk factors for atherosclerosis in heart transplant recipients. Am Heart J. 1994;128:68-72.
9. Valantine HA, Rickenbacher P, Kemna M, Hunt S, Chen I, Reaven G, Metabolic abnormalities of syndrome X predict the development of coronary artery disease. J Heart Transplant. 1994;14:S58. Abstract.
10. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall Study. BMJ. 1983;287:867-870.
11. Ross R, Agius L. The process of atherogenesis: cellular and molecular interactions: from experimental models to humans. Diabetologia. 1992;35(suppl 2):S34-S40.
12. Tanaka H, Sukhova GK, Libby P. Interaction of the allogeneic state and hypercholesterolemia in arterial lesion formation in experimental cardiac allografts. Arterioscler Thromb. 1994;14:734-745.
13. Adams DH, Tilney NL, Collins JJ, Karnovsky MJ. Experimental atherosclerosis, I: the Lewis-to-F344 allograft model. Transplantation. 1992;53:1115-1120.
14. Lurie KG, Billingham ME, Jamieson SW, Harrison DC, Reitz BA. Pathogenesis and development of graft atherosclerosis in an experimental heart transplant model. Transplantation. 1981;31:41-47.
15. Jeppesen J, Chen YD, Zhou MY, Wang T, Reaven CM. Effect of variations in oral fat and carbohydrate load on postprandial lipemia. Am J Clin Nutr. 1995;62:1201-1205.
16. Dall' Aglio E, Tosini P, Zavaroni I, Olivetti G, Reaven GM. Comparison of the metabolic changes in rats with hypertension secondary to fructose feeding or renal artery stenosis. Am J Hypertens. 1995;80(pt 1):524-527.
17. Ono K, Lindsey E. Improved technique of heart transplantation in rats, J Thorac Cardiovasc Surg. 1969;57:225-229.
18. Kadish AH, Litle RL, Sternberg JC. A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem. 1968;14:116-131.
19. Wahlefeld AW, Triglycerides: determination after enzymatic hydrolysis. In: Bergmeyer HU, ed. Methods of Enzymatic Analysis. New York, NY: Academic Press: 1974:1831-1835.
20. Allain CA, Poon LS, Chan CSG, Richard W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470-475.
21. Billingham ME. Diagnosis of cardiac rejection by endomyocardial biopsy. Heart Transplant. 1981;2:25-30.
22. Schmid C, Heemann U, Tilney NL. Retransplantation reverses mononuclear infiltration but not myointimal proliferation in a rat model of chronic cardiac allograft rejection. Transplantation. 1996;61:1695-1699.
23. Mennander A, Tikkanen MJ. Räisänen-Sokolowski A, Paavonen T, Ustinov J, Häyry P. Chronic rejection in rat aortic allografts. IV: effect of hypercholesterolemia in allograft arteriosclerosis. J Heart Lung Transplant. 1993;12:123-132.
24. Russell PS, Chase CM, Colvin RB. Accelerated atheromatous lesions in mouse hearts transplanted to apolipoprotein-E-deficient recipients. Am J Pathol. 1996;149:91-99.